HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Aug. 9, 2005--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that the Company’s NicAlert(TM) product will be used in routine assessment as part of the Tobacco Free Babies Program at the Washoe Pregnancy Center in Reno, Nevada. The Program is funded by the State of Nevada and includes tobacco dependence interventions and referrals to the Nevada Tobacco Users Helpline for cessation and exposure reduction.
